Results 131 to 140 of about 42,337 (292)

Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia. [PDF]

, 1992
D.A. Winfield, S V Polacarz
openalex   +1 more source

The PNH French Working Group Experience: Building a Strong Network of Cytometrists

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The PNH working group was created in 2010 to initiate a workshop on testing white blood cells to share international recommendations. Methods Thirty‐five French and Belgian laboratories equipped with 2‐ or 3‐laser cytometers applied three different panels with or without FLAER reagent in 305 samples.
Orianne Wagner‐Ballon, Magali Le Garff‐Tavernier, Rémi Lestestu, Bernard Drenou, Agathe Debliquis, the PNH French Working Group «CytHem‐HPN», Chantal Fossat, Claire Loosen, Bernard Chatelain, Marie Loosveld   +9 more
wiley   +1 more source

Bloom's Syndrome Complicated by Myelodysplastic Syndrome and Multiple Neoplasia.

, 1993
Yoshihito Iwahara, Kazuyoshi� Ishii, Seiji Watanabe, Hirokuni Taguchi, Hiroshi Hara, Isao Miyoshi   +5 more
openalex   +2 more sources

Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone? [letter; comment] [PDF]

, 1994
P. Musto, Antonietta Falcone, M Carotenuto, Lucio Catalano, A Cennamo, Bruno Rotoli   +5 more
openalex   +1 more source

Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The majority of patients with essential thrombocythemia (ET) show somatic mutations of JAK2, CALR, or MPL. Around 10% of cases lack these mutations (“triple negative” ET, TN‐ET). Additionally, some patients with bona fide “primary thrombocytosis” (PT) [i.e., high platelet (PLT)‐ count with no apparent underlying causes] do not ...
Valentina Sangiorgio, Federica Mottadelli, Fabio Pagni, Fabrizio Cavalca, Giovanni Cazzaniga, Martina Venegoni, Carlo Gambacorti‐Passerini, Rocco Piazza, Elena Maria Elli   +8 more
wiley   +1 more source

Detection of Monoclonal Hematopoiesis Using Restriction Fragment Length Polymorphism(RFLP) of Phosphoglycerokinase(PGK) Gene in a Patient with Hypoplastic Myelodysplastic Syndrome(MDS).

, 1993
Yasushi Miyazaki, Kazutaka Kuriyama, Tsuneo FUJWARA, Itsuro Jinnai, Kunitake Hirashima, Masao Tomonaga   +5 more
openalex   +2 more sources

Time‐Dependent EDTA Effect on Leukocyte Differential Count and Morphology Compared to Blood Smear Made by Direct Finger Prick

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The impact of ethylenediaminetetraacetic acid (EDTA) on leukocyte count and morphology has led to the current recommendation that smears made from EDTA blood should be prepared within 4 h of sampling. However, previous studies have only been performed on smears with normal cell counts, and smears made from K2EDTA blood have not ...
Anna Irding, Filip Landgren, Elisabeth Aardal   +2 more
wiley   +1 more source

How Trustworthy is Light Transmittance Platelet Aggregometry With Low Platelet Count Samples? Insights From Test Replicates and Retrospective Analysis of Several Decades of Diagnostic Samples

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Light transmission platelet aggregometry (LTA) is useful to diagnose platelet function disorders (PFD). We evaluated the precision and reproducibility of LTA with low platelet count platelet‐rich plasma (LPRP). Methods LPRP maximal aggregation (MA) precision for informative agonists and LTA reproducibility were assessed using ...
Catherine P. M. Hayward, Rabab Al Dawood, Lindsay Wice, Karen A. Moffat   +3 more
wiley   +1 more source

Advances and challenges in the treatment of myelodysplastic syndromes. [PDF]

Exp Hematol Oncol
Thalla R, Mack R, Kosti-Schwartz J, Breslin P, Zhang J.   +4 more
europepmc   +1 more source

The Application of Artificial Intelligence‐Based Bone Marrow Cell Analysis System in Pediatric Hematological Diseases

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The clinical diagnosis of hematological diseases depends on the differential count of nucleated cells on the bone marrow (BM) smears, and an artificial intelligence (AI)‐based system was applied to automatically classify BM nucleated cells in pediatric hematological disease samples in this study.
Xin He, Fei He, Yan Wang, Yu Liu, Xiaopeng Gao, Mingrui Yu, Haiyan Gao   +6 more
wiley   +1 more source